Security Snapshot

scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) Institutional Ownership

CUSIP: 810648105

13F Institutional Holders and Ownership History from Q4 2017 to Q4 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$5.67

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
SCPH
Shares outstanding
53,364,241
Price per share
$5.67
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 810648105.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 108 to 0 between Q3 2025 and Q4 2025.
  • Reported value moved from $232,212,551 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Security key

810648105

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

SCPH full holder history scPharmaceuticals Inc. SEC filings scPharmaceuticals Inc. company facts scPharmaceuticals Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Significant Owners of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GLAZER CAPITAL, LLC 4.6% $11,829,640 2,474,820 Glazer Capital, LLC 02 Sep 2025
KING LUTHER CAPITAL MANAGEMENT CORP 4% -43% $11,982,841 -$8,674,586 2,128,391 -42% Luther King Capital Management Corporation 30 Sep 2025

Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$232,019,584 $5.67 0
2025 Q3 40,958,051 $232,212,551 +$31,413,737 $5.67 108
2025 Q2 38,194,973 $145,545,847 +$3,415,856 $3.81 95
2025 Q1 37,545,308 $98,742,458 -$7,793,831 $2.63 87
2024 Q4 39,775,602 $140,807,820 +$5,279,129 $3.54 84
2024 Q3 37,253,566 $169,822,547 +$42,711,046 $4.56 93
2024 Q2 27,815,340 $121,012,490 +$4,504,277 $4.35 77
2024 Q1 26,737,974 $134,225,727 -$7,908,753 $5.02 76
2023 Q4 27,975,859 $175,412,395 -$21,478,357 $6.27 79
2023 Q3 29,932,073 $213,117,843 +$9,111,651 $7.12 73
2023 Q2 28,536,920 $290,787,599 +$40,687,005 $10.19 81
2023 Q1 24,606,169 $223,185,472 +$38,842,993 $9.07 63
2022 Q4 21,410,510 $153,514,412 +$53,537,608 $7.17 59
2022 Q3 14,022,022 $91,281,927 -$10,765,163 $6.52 38
2022 Q2 15,695,145 $75,930,511 -$3,255,361 $4.82 37
2022 Q1 15,882,655 $90,121,602 -$464,823 $5.68 34
2021 Q4 15,935,241 $79,992,923 -$1,598,866 $5.02 29
2021 Q3 16,228,718 $107,917,705 +$1,557,655 $6.65 29
2021 Q2 16,027,286 $97,921,582 -$7,160,512 $6.11 35
2021 Q1 17,151,321 $114,054,500 +$1,499,774 $6.65 45
2020 Q4 16,944,254 $89,636,480 -$6,272,494 $5.29 46
2020 Q3 17,093,245 $127,345,487 -$3,281,426 $7.45 48
2020 Q2 17,536,133 $129,064,483 +$37,153,425 $7.36 51
2020 Q1 12,488,415 $92,413,167 +$10,168,930 $7.40 32
2019 Q4 11,121,954 $62,947,464 +$1,581,064 $5.65 27
2019 Q3 7,577,638 $44,502,550 +$1,469,868 $5.89 24
2019 Q2 7,370,534 $23,510,457 -$286,179 $3.19 28
2019 Q1 7,483,932 $22,451,653 -$1,275,253 $3.00 32
2018 Q4 7,846,766 $29,504,290 -$830,389 $3.76 32
2018 Q3 8,056,307 $47,291,256 -$192,971 $5.87 31
2018 Q2 8,090,838 $45,789,211 -$6,149,684 $5.66 37
2018 Q1 8,320,407 $103,170,760 +$6,465,196 $12.40 37
2017 Q4 7,806,672 $94,381,000 +$94,381,000 $12.09 24
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .